Prestige Consumer Healthcare (PBH) Long-Term Deferred Tax (2018)
Prestige Consumer Healthcare (PBH) posted quarterly Long-Term Deferred Tax of $26000.0 for Q1 2018.
Prestige Consumer Healthcare (PBH) Long-Term Deferred Tax (2018) Analysis & Trends
Prestige Consumer Healthcare's Long-Term Deferred Tax history runs 1 years deep, the most recent figure standing at $26000.0 for Q1 2018.
- In Q1 2018, Long-Term Deferred Tax changed N/A year-over-year to $26000.0; the TTM figure through Mar 2018 stood at $26000.0 (changed N/A YoY), while the FY2018 annual figure was $26000.0, changed N/A from the prior year.
- Long-Term Deferred Tax for Q1 2018 stood at $26000.0.
- The five-year high for Long-Term Deferred Tax was $26000.0 in Q1 2018, with the low at $26000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 26,000.00 |